19.06.2018
- Albuvirtide, a new drug developed by Frontier Biotechnologies in China, is claimed to be the world's first long-acting fusion inhibitor for HIV. It works by blocking the fusion...
27.07.2015
- The US Food and Drug Administration has designated the Bristol-Mayers Squibb experimental HIV drug BMS-663068 as a breakthrough treatment, which could accelerate its approval. The...
20.11.2012
- In A Clinch - Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient advocacy groups, investors, physicians and even other...
